2019
DOI: 10.1016/j.jpha.2019.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Carbon nanotubes: Evaluation of toxicity at biointerfaces

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
109
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 227 publications
(132 citation statements)
references
References 68 publications
3
109
0
Order By: Relevance
“…Nevertheless, possible toxicity of nanomaterials limits CNTs' medical applications [24], even though reports to date are scarce and inconclusive, e.g., for the neurotoxic effects of CNTs [25], or CNTs formation of reactive oxygen species [26]. There are more reports on the lack of adverse effects of CNTs than on their long-term toxicity [24].…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, possible toxicity of nanomaterials limits CNTs' medical applications [24], even though reports to date are scarce and inconclusive, e.g., for the neurotoxic effects of CNTs [25], or CNTs formation of reactive oxygen species [26]. There are more reports on the lack of adverse effects of CNTs than on their long-term toxicity [24].…”
Section: Introductionmentioning
confidence: 99%
“…Figure 1. Main nanosystems tested for the treatment of lung cancer Source: Adapted from Cho et al (23) ; Mohanta et al (24) ; Pinho & Figueiras (25) ; Zaborski (26) ; Sharma et al (27) Nanocarriers have the potential to modify the properties of drugs by increasing their efficacy, stability and solubility, as well as reducing their toxicity and sustaining their release (18,22) . The first drug inserted in nanoparticles and approved by the US Food and Drug Administration (FDA) was DOXIL ( Figure 2), which is doxorubicin encapsulated in a lipid nanoparticle.…”
Section: Resultsmentioning
confidence: 99%
“…Concerning the use of nanomaterials, an in‐depth nanotoxicity assessment needs to be carried out to ensure the safe use for both the manufacturers' operators and the end‐users. Some studies have already been reported, [ 97,267–271 ] but further understanding of all the possible toxicity aspects and long‐term effects is needed.…”
Section: Prospects Future Challenges and Conclusive Remarksmentioning
confidence: 99%